Remove 2016 Remove Develop Remove Patents Remove Sales
article thumbnail

Interview with Marcus Filipovich, Ocular Data Systems

socalTECH

Marcus Filipovich: I joined as Chief Executive Officer in January of 2016, however, our founders are really the pioneers in the area of using eye signs for drug enforcement. That's a bridge to our Series A, which we'll be using for scaling up sales and marketing. How did the company and its technology come about?

article thumbnail

10 Answers That Make Your Startup Plan Investable

Startup Professionals Musings

Entrepreneurs who are looking to attract investors need to develop and pitch a plan -- preferably written -- that answers every potential investor question about your startup before it is asked. This is also the place to first mention patents and any other differentiators that put you ahead of competition.

Invest 108
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

All those years of hard work to reach the promised land, then just as a drug owner is ready to spike it home and take a victory lap, the FDA’s hands rise over the net… OK, it’s not a perfect analogy, but it’s better than comparing the patent fight over the gene editing system CRISPR-Cas9 to table tennis. (Be

article thumbnail

Join The Unicorn Club Of Billion-Dollar Companies

Startup Professionals Musings

If your new venture is still in the idea or development stages, don’t even think about a high valuation. Patents and other intellectual property are a necessary initial “barrier to entry,” but these are just the beginning. Marty Zwilling First published on Inc.com on 09/29/2016. Strong intellectual property and defensibility.

Company 100